Sonoma Pharmaceuticals, Inc.
(NASDAQ : SNOA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.79%17.662.0%$111.93m
SAGESAGE Therapeutics, Inc.
1.80%160.939.5%$82.08m
JAZZJazz Pharmaceuticals Plc
0.49%125.932.2%$74.89m
ICPTIntercept Pharmaceuticals, Inc.
-0.34%110.8218.6%$68.57m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.53%150.496.3%$65.14m
PRGOPerrigo Co. Plc
0.76%48.976.8%$61.26m
PTLAPortola Pharmaceuticals, Inc.
3.86%30.967.7%$42.74m
CTLTCatalent Inc
1.06%42.022.4%$41.89m
ICLRICON Plc
0.67%145.054.1%$35.72m
UTHRUnited Therapeutics Corporation
0.92%119.6314.4%$31.22m
HZNPHorizon Pharma plc
1.05%23.177.4%$30.97m
CORTCorcept Therapeutics Incorporated.
3.69%11.805.5%$28.89m
AERIAerie Pharmaceuticals, Inc.
1.66%41.756.9%$28.04m
IRWDIronwood Pharmaceuticals, Inc. Class A
9.20%15.2010.1%$27.87m
MDCOMedicines Company
3.17%24.7721.8%$27.83m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.